🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06492148
Recruiting Not applicable

Myofascial Release Technique in Women With Primary Dysmenorrhea

NCT06492148 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-09-10
Last updated
2024-11-21

Condition(s) studied

Dysmenorrhea PrimaryCentral SensitisationMyofascial Trigger Point PainMenstrual DiscomfortMyofascial Release

Investigational drug(s) / intervention(s)

Myofascial ReleaseSham-Myofascial Release

Myofascial Release: The myofascial release technique is a widely used manual therapy method characterized by low-load, prolonged mechanical forces applied to manipulate the myofascial complex, aiming to restore optimal length, alleviate pain, and improve function.

Sham-Myofascial Release: The hands of the researcher applying the technique will be placed in the same areas as the myofascial release technique, with only the palms in light contact for the same duration. However, no intervention will be made to create any pressure or open the tissue barrier.

Study summary

It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex. This technique aims to restore optimal length, alleviate pain, and improve function. This study aims to examine the effect of the myofascial release technique on central sensitization, myofascial trigger points, and menstrual symptoms in women with primary dysmenorrhea.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide, * Having regular menstruation in the last 6 months (28±7 days) * Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months Exclusion Criteria: * Diagnosed with Secondary Dysmenorrhea, * Having given birth, * Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes, * Undergoing urogynecological surgery, * Those who are pregnant or suspected of pregnancy, * Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain, * Those using intrauterine or oral contraceptives, * Those taking extra supplements such as magnesium, which may affect treatment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Gazi University Ankara Turkey (Türkiye) Recruiting

More Gazi University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06492148 on ClinicalTrials.gov ↗ ← All trials in Turkey